Notably, when stratifying the cohort by ER status, high stathmin expression alone predicted BRCA1 mutations among ER negative tumours (p = 0.002; Table 3), whereas in ER positive tumours, none of the above-mentioned markers could predict BRCA1 positive status. This evidence concerns the gene BRCA1 and neoplasm.